Read the full press release >> Aug 21, 2025 9:00 AM Eastern Daylight Time BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–OM1, a leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, today announced that its Rheumatoid Arthritis (RA) specialty dataset achieved the highest quality score in an independent, AI-powered evaluation conducted by[…]
Read the press release >> Aug 12, 2025 9:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, a leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, today announced the expansion of its Neurology Specialty Network with the addition of 500,000 patients. The network now includes over 3 million individuals with electronic[…]
Read the full press release >> Aug 5, 2025 9:00 AM Eastern Daylight Time Lane to lead product and engineering strategy, driving innovation and growth in AI-powered real-world evidence and outcomes solutions for healthcare BOSTON–(BUSINESS WIRE)–OM1, the leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, today announced the appointment[…]
Read the full article >> The Evidence Base May 19, 2025 In large clinical trials, glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated significant effectiveness in improving glycemic control and reducing cardiovascular risk. However, recent concerns have arisen following reports suggesting a potential association between GLP-1 receptor agonists and increased risk of suicidal ideation (SI) and[…]
Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, a leading provider of AI-driven insights for life sciences and healthcare organizations, today announced a major milestone in the development of its groundbreaking PhenOM® Foundation Model. The model has now been trained on more than one billion years of patient health histories, representing the largest model of its[…]
